Evidence map›Paper›PMID 36882539›Full record

ArticleJA clinical reports2023

Delayed-onset contact dermatitis caused by olanexidine gluconate antiseptic solution: effect of wiping off the remaining drug solution in two cases.

Kasumi Boki Yamamoto, Keisuke Fujii, Kazuhiro Mizumoto, Tadashi Tanioku, Tomoyuki Kawamata

Open access · goldAbstract read
In one paragraph

Article in JA clinical reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Journal of medical microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kasumi Boki YamamotoDepartment of Anesthesiology, School of Medicine, Wakayama Medical University Hospital, 811-1 Kimiidera, Wakayama, 641-8510, Japan.
Keisuke FujiiDepartment of Anesthesiology, School of Medicine, Wakayama Medical University Hospital, 811-1 Kimiidera, Wakayama, 641-8510, Japan.
Kazuhiro MizumotoDepartment of Anesthesiology, School of Medicine, Wakayama Medical University Hospital, 811-1 Kimiidera, Wakayama, 641-8510, Japan.
Tadashi TaniokuDepartment of Anesthesiology, School of Medicine, Wakayama Medical University Hospital, 811-1 Kimiidera, Wakayama, 641-8510, Japan.
Tomoyuki KawamataDepartment of Anesthesiology, School of Medicine, Wakayama Medical University Hospital, 811-1 Kimiidera, Wakayama, 641-8510, Japan. kawamata@wakayama-med.ac.jp.ORCID http://orcid.org/0000-0003-1535-6715
Wakayama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOlanexidine glucuronide (Olanedine®), an antiseptic solution may cause skin dermatitis around one week after disinfection. Although removal after the procedure is recommended to avoid skin dermatitis, whether it is effective for preventing skin dermatitis has not been documented in detail in the literature. CASE PRESENTATION: We encountered two cases of delayed-onset contact dermatitis by Olanedine®. In both cases, the patient's back was disinfected with Olanedine® and was covered with a surgical drape for epidural catheterization. After catheterization and removal of the surgical drape, the insertion site of the catheter was covered with a film dressing, then the epidural catheter was taped to the back. On the third postoperative day, the epidural catheter was removed. On the seventh postoperative day, the patients reported pruritus on the back, where an erythematous papule rash was observed. However, it was not observed at the site covered by the tape to secure the epidural catheter or by the tape of the surgical drape. Symptoms were relieved with oral or topical steroids by the time of discharge.

conclusionWiping off the remaining Olanedine® even a few days after disinfection may be helpful not only for reducing symptoms but also for preventing the development of contact dermatitis.

Indexed as

DermatitisDisinfectionOlanexidine

Identifiers

PMID36882539
PMCPMC9992490
OpenAlexW4323534943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.